Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label Trial to Compare the Efficacy and Safety of Early Initiation of cART With or Without Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in Treatment-Naïve Acute HIV-1 Infected Adults

NCT02231281 is registered in ClinicalTrials.gov with Yongtao Sun, MD, PhD as lead sponsor.

NCT NCT02231281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02231281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label Trial to Compare the Efficacy and Safety of Early Initiation of cART With or Without Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in Treatment-Naïve Acute HIV-1 Infected Adults
Lead sponsor
Yongtao Sun, MD, PhD
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2014
Completion date
December 31, 2018
Enrollment
65 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute hiv infection